Back to COGT

Kynam Capital Management, LP → COGT

Kynam Capital Management, LP COGT Position History

Cogent Biosciences, Inc. • Healthcare

Quarters held
4
Latest value
$121.4M
Q3 2026
Peak value
$219M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$219M
Q1 2026$155.4M
Q2 2026$141.9M
Q3 2026$121.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$121.4M3.79M——
Q2 2026$141.9M3.67M——
Q1 2026$155.4M4.04M——
Q4 2025$219M6.17M——

Other funds holding COGT

Other Kynam Capital Management, LP positions

CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M
PCVX

VAXCYTE INC

$169.8M